Amphastar Pharmaceuticals (AMPH) Institutional Ownership
13F filers reported holding 28.0% of Amphastar Pharmaceuticals (AMPH) shares as of Sep 30, 2026, across 144 filers.
- Held by 13F filers
- 28.0%
- Sep 30, 2026
- 13F filers
- 144
- quarter ended Sep 30, 2026
- 13F value
- $309.1M
- 12.0M shares
- Quarter's fund flow
- Mild accumulation
- 22 new · 10 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Acquired · Option exercise | 11,000 | $17.99 | ↗ |
| Nov 5, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Open-market sale | 12,631 | $28.99 | ↗ |
| Nov 5, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Option exercise | 11,000Employee Stock Option (right to buy) | — | ↗ |
| Nov 4, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Acquired · Option exercise | 16,000 | $13.03 | ↗ |
| Nov 4, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Open-market sale | 16,000 | $28.03 | ↗ |
| Nov 4, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Option exercise | 16,000Employee Stock Option (right to buy) | — | ↗ |
| Sep 21, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Open-market sale | 4,139 | $25.00 | ↗ |
| Sep 16, 2026 | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | Acquired · Option exercise | 10,000 | $13.35 | ↗ |
| Sep 16, 2026 | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | Disposed · Open-market sale | 10,000 | $23.94 | ↗ |
| Sep 16, 2026 | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | Disposed · Option exercise | 10,000Employee Stock Option (right to buy) | — | ↗ |
| Sep 2, 2026 | Zhou Rong | SENIOR EVP, PRODUCTION CENTER | Disposed · Open-market sale | 3,187 | $23.63 | ↗ |
| Aug 11, 2026 | PRINS RICHARD K | director | Disposed · Open-market sale | 7,973 | $20.30 | ↗ |
| Aug 7, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Acquired · Option exercise | 5,053 | $19.79 | ↗ |
| Aug 7, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Open-market sale | 8,180 | $22.48 | ↗ |
| Aug 7, 2026 | PETERS WILLIAM J | CFO, EVP & TREASURER | Disposed · Option exercise | 5,053Employee Stock Option (right to buy) | — | ↗ |
| Jul 9, 2026 | Pierce Anthony T | director | Acquired · Grant / award | 7,886 | — | ↗ |
| Jul 9, 2026 | Pierce Anthony T | director | Acquired · Grant / award | 16,646Stock Option (right to buy) | — | ↗ |
| Jun 2, 2026 | Lee Howard | director | Disposed · Tax withholding | 769 | $18.45 | ↗ |
| Jun 1, 2026 | Gaugh David Russell | director | Acquired · Grant / award | 8,143 | — | ↗ |
| Jun 1, 2026 | Gaugh David Russell | director | Acquired · Grant / award | 17,365Stock Option (right to buy) | — | ↗ |
* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Amphastar Pharmaceuticals do institutions hold?
13F filers reported holding 28.0% of Amphastar Pharmaceuticals' shares as of Sep 30, 2026, across 144 filers.
How many 13F filers hold Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals was held by 144 13F filers as of Sep 30, 2026.
Not investment advice.

